Overdose Lifeline is pleased to announce a new partnership with the State of Indiana to increase access to the overdose reversal drug naloxone. Naloxone is a critical tool for individuals, families, first responders and communities to help reduce opioid overdose deaths. Access to naloxone, however, continues to be limited in some communities. The state’s partnership with Overdose Lifeline, Inc. allows local health departments to devote their resources to the COVID-19 public health emergency.
First responders, families, caregivers and other individuals in need of naloxone, click the button below to fill out a simple online request form.
During this time of COVID -19 crisis we need continued awareness that the other public health crisis, opioid use disorder, has not gone away and may potentially get worse. Responding to overdose is vital. Concerns from the community regarding the use of the nasal version of the overdose reversal drug and its potential to spread COVID-19 has been circulating.
Please read this important notice from Indiana Department of Homeland Security, Indiana Naloxone Guidance for Public Safety from Michael Kaufmann, MD Indiana EMS Medical Director.
“The CDC has confirmed that intranasal naloxone is not considered to be an aerosol generating procedure (AGP) if performed correctly.
Current recommendations are as follows:
Medication Assisted Treatment (MAT)/Medication for Opioid Use Disorder (MOUD) Prescriber Pilot Program – Extended
During this time of COVID -19 crisis we need continued awareness that the other public health crisis, opioid use disorder, has not gone away and may potentially get worse. Because of this, the Federal Government has issued new guidelines allowing for the prescribing of opioid use disorder medication without a face-to face-patient visit.
Overdose Lifeline has been able to secure additional resources to provide reimbursement for physicians, nurse practitioners and physicians assistants willing to become eligible to prescribe medication assisted treatment (MAT) / medication for opioid use disorder (MOUD).
Tools are now available to provide an evidence-based, medication to treat opioid use disorder.
Become a MAT/MOUD Waiver Prescriber
MAT/MOUD is the use of medications in combination with counseling and behavioral therapies. Research has shown that removing an individual’s drug use through detoxification without the use of medications has a high failure rate of >90% within 3 months. A common misconception associated with MAT/MOUD is that it substitutes one drug for another.
Rather, these medications relieve the withdrawal symptoms and psychological cravings that cause chemical imbalances in the body. MAT/MOUD programs provide a safe and controlled level of medication to overcome the use of an abused opioid. Research has shown that when provided at the proper dose, medications used in MAT/MOUD have no adverse effects on a person’s intelligence, mental capability, physical functioning or employability.
September 16th, San Francisco, CA - Overdose Lifeline (ODL), a nonprofit organization dedicated to helping individuals, families, and communities affected by the disease of addiction and substance use disorder and leading creative advertising agency, Venables Bell & Partners, have announced today the launch of #ChooseEmpathy. This new movement aims to create a greater understanding of the truths around addiction as well as to remove the social stigmas that surround those affected by the disease.
Overdose Lifeline's Executive Director and Founder Justin Phillips was invited to provide testimony at the final hearing of the President's Commission on Combating Drug Addiction and the Opioid Crisis. What follows is Justin's testimony.
Thank you, Governor Christie, for the invitation to join the Commission today. Your leadership has been inspiring to me in my journey. Thank you each for agreeing to take on this complex issue. Americans are suffering and as you are aware losing the battle every day.
My name is Justin Phillips and I am the mother of three children Bryan, Aaron and Audrey. Tragically I am here today because Aaron, at the early age of 20, overdosed on heroin in October of 2013 and lost his life.
My professional career was spent preventing unintentional injuries and deaths and I had a masters in nonprofit management so when I became faced with this life altering experience I knew what had to be done.
Donnelly, Murkowski Introduce Bipartisan Bill to Address Workforce Shortage to Confront Opioid Epidemic
Strengthening the Addiction Treatment Workforce Act would provide incentives for providers to practice at substance use disorder treatment facilities in underserved areas.
Thursday, June 29, 2017, as announced from Senator Joe Donnelly's office
Washington, D.C. —U.S. Senators Joe Donnelly (D-IN) and Lisa Murkowski (R-AK) announced today that they introduced the Strengthening the Addiction Treatment Workforce Act (S.1453). Their bipartisan legislation would help address the shortage of providers who treat people battling substance use disorders by making addiction treatment facilities eligible for the National Health Service Corps (NHSC) student loan repayment and forgiveness program.
This bill would allow mental health and addiction treatment facilities to expand the number of health care providers including nurses, social workers, counselors, psychologists, and therapists, who care for people struggling with substance use disorders. The National Health Service Corps facilitates recruitment and training aimed at increasing the availability of primary care services to populations in underserved areas. In Indiana, there are 59 counties that are considered underserved for primary care and 52 counties underserved for mental health care, according to the Indiana State Department of Health.
Donnelly said, “We need more substance use and addiction professionals on the frontlines to help Hoosiers and Americans across the country battling addiction to opioids or other dangerous substances. This bipartisan legislation would increase the number of providers trained to help people get the treatment they need, and I am proud to work with Senator Murkowski on this effort. As I have long said, it is going to take all of us working together to effectively combat the opioid abuse epidemic, and while we are making some progress, we still have a lot of work to do.”